The present group of inventions relates to novel compounds having formula (I), and to the salts, solvates or stereoisomers thereof, as well as to a pharmaceutical composition, a method of inhibiting the biological activity of epidermal growth factor receptor (EGFR), a method of treating diseases or disorders mediated by EGFR activity, and the use of the claimed compounds or the aforementioned composition for treating a disease or a disorder mediated by EGFR activity.發明涉及式I所示的新化合物:或其藥學上可接受的鹽、溶劑合物或立體異構體,以及含本發明化合物的藥物組合物,抑制EGFR生物活性的方法,治療由ЕGFR活化所介導的疾病或病症的方法,和本發明化合物或藥物組合物用於治療由ЕGFR活化所介導的疾病或病症的用途。